BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10460590)

  • 1. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.
    Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ
    Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelets display high-affinity receptors for thrombopoietin.
    Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K
    Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelets as a model for the binding and degradation of thrombopoietin.
    Fielder PJ; Hass P; Nagel M; Stefanich E; Widmer R; Bennett GL; Keller GA; de Sauvage FJ; Eaton D
    Blood; 1997 Apr; 89(8):2782-8. PubMed ID: 9108396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
    Li J; Xia Y; Kuter DJ
    Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
    Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
    Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
    Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
    Alexander WS
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J; Sabath DF; Kuter DJ
    Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.
    Scheding S; Bergmann M; Shimosaka A; Wolff P; Driessen C; Rathke G; Jaschonek K; Brugger W; Kanz L
    Transfusion; 2002 Mar; 42(3):321-7. PubMed ID: 11961237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.
    Tamura H; Ogata K; Luo S; Nakamura K; Yokose N; Dan K; Tohyama K; Yoshida Y; Hamaguchi H; Sakamaki H; Kuwaki T; Tahara T; Kato T; Nomura T
    Br J Haematol; 1998 Dec; 103(3):778-84. PubMed ID: 9858230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
    Griesshammer M; Bangerter M; Schrezenmeier H
    Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin and the TPO receptorduring platelet storage.
    Xia Y; Li J; Bertino A; Kuter DJ
    Transfusion; 2000 Aug; 40(8):976-87. PubMed ID: 10960526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.